Certificate of compliance under Reg. 74 (5) of SEBI (DP) for quarter ended 30.06.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kobo Biotech Limited has submitted a routine compliance certificate to BSE from its Registrar and Share Transfer Agent (XL Softech Systems Ltd.) confirming that all securities received for dematerialization during the quarter ended 30 June 2025 were properly confirmed to the depositories (NSDL/CDSL) and that share certificates were mutilated and cancelled within 30 days, with the depository's name substituted in the register of members. The filing has been signed by Namrata Randeri, who is acting as the Insolvency Professional, and the correspondence email is a CIRP-specific address, indicating the company is currently under Corporate Insolvency Resolution Process. The filing is dated 4 February 2026, which is significantly delayed relative to the June 2025 quarter it pertains to.
This is largely a procedural compliance filing and unlikely to move the stock price on its own. However, the presence of an Insolvency Professional and CIRP-related email confirms that Kobo Biotech remains under insolvency resolution, which is a critical risk factor existing shareholders should be aware of.